Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38,610Revenue $M1,551Net Margin (%)23.3Z-Score32.3
Enterprise Value $M36,985EPS $1.3Operating Margin %38.7F-Score8
P/E(ttm))81.0Cash Flow Per Share $0.8Pre-tax Margin (%)38.8Higher ROA y-yY
Price/Book12.410-y EBITDA Growth Rate %0Quick Ratio4.8Cash flow > EarningsY
Price/Sales18.95-y EBITDA Growth Rate %52.4Current Ratio5.1Lower Leverage y-yY
Price/Cash Flow115y-y EBITDA Growth Rate %59.3ROA % (ttm)14.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)18.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M198ROI % (ttm)16.0Gross Margin Increase y-yY

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALXNAndreas Halvorsen 2014-09-30 Add0.13%$155.06 - $173.08
($164.22)
$ 194.7219%Add 9.59%2,198,451
ALXNRon Baron 2014-09-30 Add$155.06 - $173.08
($164.22)
$ 194.7219%Add 27.56%12,941
ALXNJoel Greenblatt 2014-09-30 Reduce-0.03%$155.06 - $173.08
($164.22)
$ 194.7219%Reduce -89.45%1,804
ALXNRay Dalio 2014-09-30 Sold Out -0.03%$155.06 - $173.08
($164.22)
$ 194.7219%Sold Out0
ALXNAndreas Halvorsen 2014-06-30 Add0.12%$139.61 - $170.2
($157.93)
$ 194.7223%Add 9.23%2,006,092
ALXNJoel Greenblatt 2014-06-30 Add0.02%$139.61 - $170.2
($157.93)
$ 194.7223%Add 240.11%17,094
ALXNRay Dalio 2014-06-30 Reduce-0.03%$139.61 - $170.2
($157.93)
$ 194.7223%Reduce -47.72%26,332
ALXNJohn Burbank 2014-06-30 Sold Out -0.01%$139.61 - $170.2
($157.93)
$ 194.7223%Sold Out0
ALXNRay Dalio 2014-03-31 Buy 0.06%$129.82 - $183.89
($158.27)
$ 194.7223%New holding, 50371 sh.50,371
ALXNJoel Greenblatt 2014-03-31 Buy 0.01%$129.82 - $183.89
($158.27)
$ 194.7223%New holding, 5026 sh.5,026
ALXNRon Baron 2014-03-31 Buy 0.01%$129.82 - $183.89
($158.27)
$ 194.7223%New holding, 10218 sh.10,218
ALXNJohn Burbank 2014-03-31 Buy 0.01%$129.82 - $183.89
($158.27)
$ 194.7223%New holding, 1318 sh.1,318
ALXNFrank Sands 2014-03-31 Reduce-0.74%$129.82 - $183.89
($158.27)
$ 194.7223%Reduce -28.52%5,268,418
ALXNAndreas Halvorsen 2014-03-31 Reduce-0.65%$129.82 - $183.89
($158.27)
$ 194.7223%Reduce -36.16%1,836,658
ALXNAndreas Halvorsen 2013-12-31 Reduce-0.37%$105.48 - $132.91
($119.84)
$ 194.7262%Reduce -16.72%2,877,008
ALXNAndreas Halvorsen 2013-09-30 Reduce-1.06%$94.34 - $117.28
($109.83)
$ 194.7277%Reduce -37.7%3,454,640
ALXNFrank Sands 2013-09-30 Reduce-0.27%$94.34 - $117.28
($109.83)
$ 194.7277%Reduce -10.5%7,540,405
ALXNAndreas Halvorsen 2013-06-30 Reduce-2.15%$87.99 - $107.86
($96.37)
$ 194.72102%Reduce -41.4%5,544,949
ALXNAndreas Halvorsen 2013-03-31 Add2.99%$83.39 - $102.57
($93.13)
$ 194.72109%Add 135.72%9,462,442
ALXNFrank Sands 2013-03-31 Add0.11%$83.39 - $102.57
($93.13)
$ 194.72109%Add 4.23%8,420,336
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALXN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ALXN Ron Baron 2014-09-3012,9410.010.01+27.56%
ALXN Andreas Halvorsen 2014-09-302,198,4511.111.5+9.59%
ALXN Frank Sands 2014-09-305,311,4882.682.2+0.6%
ALXN Joel Greenblatt 2014-09-301,80400-89.45%
ALXN Ray Dalio 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BELL LEONARDCEO 2014-11-20Sell5,210$191.961.14view
PARVEN ALVIN SDirector 2014-11-11Sell15,000$195.66-0.77view
Sinha VikasEVP & CFO 2014-11-06Sell5,693$195-0.44view
Hallal DavidCOO 2014-11-03Sell30,000$190.012.18view
MACKAY MARTINEVP & Global Head of R&D 2014-11-03Sell9,375$191.521.37view
Islam SaqibSVP, Chief Strat & Port. Off. 2014-11-03Sell28,125$190.51.92view
Sinha VikasEVP & CFO 2014-11-03Sell49,307$192.630.79view
Moriarty John BSVP & General Counsel 2014-10-27Sell10,000$189.492.46view
SQUINTO STEPHEN PEVP, Chief Global Ops. Officer 2014-10-27Sell5,910$188.582.95view
Moriarty John BSVP & General Counsel 2014-10-06Sell10,000$1798.46view

Press Releases about ALXN :

    Quarterly/Annual Reports about ALXN:

    News about ALXN:

    Articles On GuruFocus.com
    CEO of Alexion Pharmaceuticals Sells Company Stock Sep 29 2014 
    Alexion CEO Receives Nearly $17 Million for Sale of Company Stock Aug 14 2014 
    Weekly CFO Sells Highlight: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc., Therm Feb 10 2014 
    Weekly Insider Sells Highlight: EA, ALXN, AAL, TMO Feb 09 2014 
    You Can No Longer Ignore Biotech Feb 07 2014 
    Six High-Impact Sells - Viking Global Investors Aug 26 2013 
    CEO of Alexion Pharmaceuticals Inc. Leonard Bell Sold 140,000 Shares Aug 19 2013 
    Weekly CFO Sells Highlight: USB, SGEN, CAH, ALXN, ABMD Jul 21 2013 
    fv 107 Apr 01 2013 
    Weekly Top Insider Sells: GOOG, KSS, ALXN, and QCOM Sep 03 2012 

    More From Other Websites
    Has Alexion Pharmaceuticals Healed From Its Bad Break? Nov 20 2014
    Are consumers getting gouged on health care? Nov 18 2014
    Here Are Some Big Caps Poised To Make Gains Nov 17 2014
    Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS... Nov 15 2014
    Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS... Nov 15 2014
    Alexion, EA: Two Top Stocks Form Good Chart Patterns Nov 14 2014
    Taking Stock: Iqbal Favors Oil, Transportation, Health Care Nov 14 2014
    Big Cap 20 Stuffed With Medical Names Nov 10 2014
    ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Nov 10 2014
    Alexion Pharma co-founder Squinto to retire Nov 10 2014
    Alexion Pharma co-founder Squinto to retire Nov 10 2014
    Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global... Nov 10 2014
    Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global... Nov 10 2014
    Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the... Nov 06 2014
    Top Funds Buy Ulta Beauty, Alexion, Avago Nov 04 2014
    Big Cap 20: Health Care, Tech Stocks Rule The Roost Nov 03 2014
    ALEXION PHARMACEUTICALS INC Financials Oct 31 2014
    Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen Oct 29 2014
    Top Holdings Of Top Health Care Funds: Alexion, Gilead, Celgene Oct 28 2014
    Four Biotechs Lead Health Care Stocks In Big Cap 20 Oct 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK